{'fraction_non_alphanumeric': 0.01699029126213592, 'fraction_numerical': 0.009708737864077669, 'mean_word_length': 5.544973544973545, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
The future of cytology laboratories

This presentation will consider the impact of established and potential changes to cervical screening practice on the structure and organisation of cervical cytology laboratories in the UK. Although full roll out of liquid based cytology in England will not be achieved until 2008, implementation of liquid‐based cytology (LBC) combined with the change in the screening age range and frequency has already resulted in a decrease in the total number of tests examined despite an increased number of women aged 25–64 being screened, reflecting a more efficient screening programme with fewer unnecessary tests outside the recommended screening age range [1]. Laboratories in England and Scotland have reported a decreased workload and increased productivity and efficiency, with no adverse effect on quality [2–4]. There is a growing mismatch between screening workload and capacity, with the potential to achieve laboratory reconfiguration within a managed network, as recommended in the Carter report [5]. However the potential for conflict between the Carter report recommendations and the autonomy of NHS foundation trusts will need to be addressed if laboratory reconfiguration is to be achieved.